Next Article in Journal
Development of Combined Heavy Rain Damage Prediction Models with Machine Learning
Previous Article in Journal
Experimental Study on the Permeability Characteristic of Fused Quartz Sand and Mixed Oil as a Transparent Soil
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Water
Volume 11
Issue 12
10.3390/w11122515
water-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Removal of Organic Micropollutants in Wastewater Treated by Activated Sludge and Constructed Wetlands: A Comparative Study

by
Carolina Reyes Contreras
1,
Daniela López
1,
Ana M. Leiva
1,
Carmen Domínguez
2,
Josep M. Bayona
2 and
Gladys Vidal
1,*
1
Engineering and Environmental Biotechnology Group, Environmental Science Faculty and EULA-Chile Centre, Universidad de Concepción, 4070386 Concepción, Chile
2
Department of Environmental Chemistry, Institute of Environmental Assessment and Water Research, IDAEA, c/Jordi Girona 18-26, E- 08034 Barcelona, Spain
*
Author to whom correspondence should be addressed.
Water 2019, 11(12), 2515; https://doi.org/10.3390/w11122515
Submission received: 22 October 2019 / Revised: 18 November 2019 / Accepted: 25 November 2019 / Published: 28 November 2019
(This article belongs to the Section Wastewater Treatment and Reuse)
Browse Figures
Review Reports Versions Notes

Abstract

:
The aim of this study is to compare the removal of organic micropollutants (OMPs) in wastewater by activated sludge (AS) and constructed wetlands (CWs). This analysis was carried out in a wastewater treatment plant (WWTP) of a rural community where they implemented two technologies in parallel: AS and a pilot plant of horizontal subsurface flow (HSSF) constructed wetlands. In this case, these systems were fed by the same influent and the removal efficiencies of 14 OMPs, including analgesics/anti-inflammatories, anticonvulsants, stimulants, antifungals, fragrances, plasticizers, and transformation products, were evaluated in each system. Regarding the presence of OMPs in the wastewater, the concentrations of these compounds in the influent ranged from 0.16 to 7.75 µg/L. In general, the removal efficiencies achieved by the AS system were between 10%–95% higher than those values reported by HSSFs with values above 80% for naproxen, ibuprofen, diclofenac, caffeine, triclosan, methyl dihydrojasmonate, bisphenol-A, 2-hydroxyl ibuprofen, and carboxy ibuprofen (p < 0.05). This behavior can be related to the aerobic conditions that promote the AS system with oxidation-reduction potential (ORP) and dissolved oxygen (DO) values above −281 mV and 0.24 mg/L, respectively. However, the removal of galaxolide was greater in HSSF system than in AS with significant difference of 70% (p < 0.05). Despite these results, this study reveals that comparing both technologies, AS had the best removal performance of these OMPs studied.

1. Introduction

In recent years, the studies related to the occurrence and fate of organic micropollutants (OMPs) have increased due to their potential toxicological effects on human health and the environment [1,2,3]. One of the principal sources of OMPs are wastewater treatment plants (WWTPs) that receive wastewater coming from domestic sewage, hospital sewage, and several human activities which contain a lot of different OMPs such as pharmaceutical and personal care products (PPCPs), pesticides, surfactants, industrial additives, and plasticizers [4,5].
The OMPs removal on WWTPs is generally influenced by the physicochemical properties of the compound; by the type of wastewater treatment technology (conventional and non-conventional) and by process-specific factors such as sludge retention time (SRT), temperature, and organic loading rates (OLR) [6]. Conventional treatment technologies are characterized by using mechanized technologies with high electrical energy requirements and the design, supervision, maintenance, and the general cost of construction that would require highly skilled workers [7]. The most common conventional wastewater treatment is activated sludge (AS) that has not been specifically designed for removing OMPs [4]. However, several studies reported that some OMPs can be removed during AS by microbial processes (biodegradation) and adsorption onto sludge flocs. One of the advantages of this technology is that oxygen conditions are an important factor for the removal of some OMPs [8]. For ibuprofen, naproxen, galaxolide, and caffeine, the removal efficiencies reported in these systems varied between 60%–99%, 25%–98%, 70%–85%, and 77%–100%, respectively [9,10,11,12]. Despite these performances, some OMPs, such as carbamazepine, were not removed during AS achieving negative percentages [9,11].
On the other hand, non-conventional wastewater treatment technologies which are based on natural processes for removing pollutants with low cost and less complex operation and design, have been implemented for treating wastewater in rural areas [13]. Constructed wetlands (CWs) are cost-effective non-conventional technologies that have shown great capacity for OMPs removal in wastewater [14]. However, their implementation is only feasible in small communities due to the large surface needed per inhabitant [15]. The mechanisms for removing OMPs involved biotic processes such microbiological degradation and biofilm and plant uptake and physicochemical processes such as absorption into the support medium, photodegradation, and evaporation. Moreover, these processes depend on the CWs design that promote the conditions for carrying out [16]. According to their wastewater flow regime, CWs can be classified as surface flow (SF), horizontal subsurface flow (HSSF), and vertical subsurface flow (VSSF) [17]. In the case of HSSF, which promotes anaerobic conditions for removing compounds, the removal efficiencies of ibuprofen, naproxen, diclofenac, triclosan, galaxolide, tonalide, and methyl dihydrojasmonate vary between 11%–92%, 45%–88%, 41%–93%, 47%–87%, 42%–95%, 36%–64%, 64%–99%, and 67%–96%, respectively [16,17,18,19].
Different studies have focused on the effectiveness of conventional and non-conventional wastewater treatment for removing OMPs. Matamoros et al. [20] evaluated the removal efficiencies of 25 OMPs in four different conventional and non-conventional WWTPs which were AS, CWs, stabilization ponds (SPs), and rotating biological contactors (RBCs). This study showed that CWs had the lowest overall removal efficiency of all the evaluated technologies. Comparing AS and CW systems, the removal of caffeine, ibuprofen, and triclosan were 1.32, 8.9, and 2.4 times higher in the conventional wastewater treatment (AS). This difference can be explained by the redox conditions of these systems. It is reported that ibuprofen and caffeine were better removed under aerobic conditions that promote AS technologies [21,22]. The same behavior was observed by Qiang et al. [23] who investigated the removal efficiencies of six OMPs in 20 rural WWTPs comparing different treatment processes: AS, CWs, SPs, and micro-power biofilm reactors (MPs). In this study, AS achieved higher performances than CWs, SPs, and MP with removal efficiencies above 70%. For bisphenol-A, the removal efficiencies of CWs fluctuated between 30%–50%, whereas AS reported values that were two times higher than CWs. Moreover, Ahmed et al. [24] made a review that focused on the removal of OMPs by biological, chemical, and hybrid technologies in effluents from WWTPs. Comparing the removal efficiencies of different groups of OMPs (including PPCPs, endocrine disrupting compounds (EDCs), pesticides, and analgesics) between AS and CWs, similar performances were obtained for EDCs and PPCPs with percentages between 84%–90% and 82%–84%, respectively. However, for pesticides and analgesics, CWs reported higher removal efficiencies which were 20% and 15% above those achieved by AS. Some of these compounds are highly polar and AS with lower retention time limited the capacity of microorganisms to metabolize. Furthermore, Melvin and Leusch [25] performed a quantitative meta-analysis to compare the removal efficiencies of PPCPs achieved by AS, oxidation ditch (OD), membrane bioreactor (MBR), ponds, and CWs. Through the standardization of removal efficiencies, the results of this study demonstrated that AS and CWs systems achieved the poorest overall removal of OMPs with values of 60% and 62%, respectively.
Within these divided opinions, the aim of this study is to compare the performance of 15 OMPs which include analgesics/anti-inflammatories, anticonvulsants, stimulants, antibacterials/antifungals, fragrances, plasticizers, and transformation products in a conventional and non-conventional wastewater technology that consists in AS and CWs, respectively. In this case, the AS technology is an extended aeration system whereas the CW consists in a pilot plant of HSSFs. Both systems treat wastewater of a rural community.

2. Materials and Methods

2.1. Description of AS and HSSF Systems

The two treatment technologies, AS and HSSF, selected for this study are located in Hualqui (36°59’26.93” S and 72°56’47.23” W), Biobío Region, Chile. Figure 1 shows a schematic diagram of AS and HSSF systems. These technologies were fed with the same influent. This raw wastewater was pre-treated (40 mm chamber bars and a sand trap), which was followed by secondary treatment (AS or HSSF). The AS began its operation in 2005 and it was designed to treat wastewater for a rural community of 20,000 inhabitants. This system consisted of an extended aeration AS with clarification. Finally, the effluent was chlorinated before being discharged into the receiving water body. Regarding operation parameters, the feeding rate, hydraulic retention time (HRT), and sludge retention time (SRT) were approximately 2211.84 m3/d, 9 h, and 25 d, respectively.
On the other hand, the CWs system was a pilot plant that consisted of a primary treatment (Imhoff tank and septic tank) followed by four parallel HSSFs units as a secondary treatment. Each HSSF had an area of 4.5 m2 (length: 3 m and width: 1.5 m) and an average depth of 0.5 m as shown in Figure 2 [26]. The theorical volume of each unit was approximately 1.28 m3. Regarding the support medium, HSSFs were filled with gravel which had a size of 19–25 mm and a porosity of 0.6%. The water level was maintained 0.10 m below the gravel surface to provide a water depth of 0.4 m. In each HSSF, three samplings tubes were installed in each zone: Zone A (the inlet zone), 0.65 m from the inlet; Zone B (middle zone), 1.4 m from the entrance point; and Zone C (the outlet zone), 2.25 m from the inlet [27]. These systems were planted with Phragmites australis (P. australis) and Schoenoplectus californicus (S. californicus). At the time of the sampling campaign, the plant densities were 327 ± 126 stems/m2 and 789 ± 124 stems/m2 for P. australis and S. californicus, respectively [27]. Regarding the operational parameters, the feeding rate and HRT were 0.088 m3/d and 5.1 d, respectively. As shown Figure 1, the four effluents generated by the different HSSFs were collected in a tank that represents the total effluent of the pilot plant of HSSFs.

2.2. Sampling Strategy

Sampling was carried out in autumn (April 2014) and different types of samples were considered for this experiment: liquid and solid. The wastewater samples were collected twice a week during 1 month (4 weeks) from the influent and AS and HSSF effluents (6 samples per week). In this case, the influent was the same for both technologies (AS and HSSF), where samples were taken after pre-treatment (chamber bars and a sand trap). The effluent samples from the AS system were taken after the chlorination process. A total of 24 wastewater samples were obtained. The samples were collected in 1 L amber glass bottles and transported under refrigeration to the laboratory, where they were stored at 4 °C and processed within 24 h.
For solids samples, biosolids from AS and gravel bed biosolids from HSSF were obtained in the final sampling. The biosolids from AS were collected in the final stage after dehydration obtaining composite samples for stabilized sludge and they were analyzed in triplicate. In the case of gravel bed biosolids from HSSF, samples were obtained for three zones of the HSSF beds: Zones A, B, and C (Figure 2). All samples were frozen at −20 °C and freeze-dried before analysis.

2.3. Analytical Methods

2.3.1. Physicochemical and Water Quality Parameters

The in situ parameters, such pH, temperature, electrical conductivity (EC), dissolved oxygen (DO), and oxidation-reduction potential (ORP), were measured in situ with all the samples using a multiparametric OAKTON-PC650 (Eutech Instruments; Singapore city Singapore). Conventional wastewater parameters, including chemical oxygen demand (COD), biological oxygen demand (BOD5), total suspended solids (TSS), volatile suspended solids (VSS), ammoniacal nitrogen (NH4+-N), and orthophosphate (PO43−-P), were analyzed following standard methods [28]. Total organic carbon (TOC) was measured using a TOC-L CPH analyzer (Shimadzu; Tokyo Japan) equipped with an ASI-L autosampler (Shimadzu; Tokyo Japan).

2.3.2. Determination of OMPs and Transformation Products by Biodegradation

The OMPs selected included analgesics/anti-inflammatories (naproxen, ibuprofen, and diclofenac), anticonvulsants (carbamazepine), stimulants (caffeine), antibacterials/antifungals (triclosan), fragrances (methyl dihydrojasmonate, tonalide and galaxolide), plasticizers (bisphenol-A), and transformation products (1-hydroxy ibuprofen, 2-hydroxy ibuprofen, carboxy ibuprofen, ibuprofen amide, and 4-hydroxy diclofenac).
For wastewater samples: The OMPs and their transformation products by biodegradation in the wastewater samples were analyzed following a previously described methodology [22]. Briefly, all the samples were filtered through a glass fiber filter with a pore size of 0.7 μm and then acidified to pH 3 using concentrated hydrochloric acid. Sample volumes of 100 mL for the influent and 250 mL for the effluent were then spiked with 0.5 μg of a surrogate standard mix (i.e., fenoprop for the acidic compounds, 2,2’-dinitrobiphenyl for the fragrances, and 10,11-dihydrocarbamazepine for the neutral compounds). Polymeric solid-phase extraction cartridges were conditioned with 5 mL of n-hexane, 5 mL of ethyl acetate, 5 mL of methanol, and 5 mL of Milli Q water (pH 3). The spiked samples were percolated through the cartridges, allowed to dry for 30 min, and eluted with 10 mL of hexane/ethyl acetate (1:1). The extract was evaporated to ca. 20 μL under a gentle nitrogen stream, and 125 ng triphenylamine were added as an internal standard. The vial was then reconstituted with ethyl acetate to a final volume of 300 μL.
Methylation of the carboxylic acidic group was performed in a hot Gas Chromatography (GC) injector (280 °C) by adding 10 μL of trimethyl sulfonium hydroxide to a 50 μL sample before injection. The derivatized samples were injected into a Bruker 320 MS GC-MS/MS in the electron impact mode (70 eV ionization energy) and fitted with a 20 m × 0.18 mm i.d. coated with 0.18 μm film thickness TRB-5 MS column purchased from Teknokroma (Sant Cugat del Vallès, Spain). Helium was used as a carrier gas (99.9995% purity) at a constant linear average speed of 40 cm s−1. The oven temperature was held at 60 °C for 3.5 min−1, then increased at 30 °C min−1 to 150 °C, and finally increased at 8 °C min−1 to 320 °C, with the final temperature held for 10 min. A sample volume of 2 μL was injected in the splitless mode at an injector temperature of 280 °C, and the purge valve was activated 50 s after the injection. The transfer line and ion source were set to 250 °C and 200 °C, respectively. The target compounds were analyzed in the multiple reaction monitoring (MRM) mode, which monitored two transitions for each compound. Physical chemical properties of the target OMPs are shown in Table 1.
The linearity range was from 0.006 to 3 μg L−1. The surrogate recoveries for the acidic, neutral compounds, and fragrances were 88 ± 3%, 81 ± 5%, and 86 ± 2%, respectively. The correlation coefficients (r2) of the calibration curves always exceeded 0.999.
For biosolids samples: The glass fiber filters containing the Suspended Solids (SS), biosolids, and gravel bed biomass was previously freeze-dried and spiked with 50 ng of the standard surrogate mix (i.e., fenoprop for acidic compounds, 2,2’-dinitrobiphenyl for fragrances, and 10,11-dihydrocarbamazepine for neutral compounds). They were then allowed to stand for 12 h at 4 °C to achieve equilibrium. Samples were extracted by sonication with 7 mL hexane-acetone (1:1, v/v) in three 10-min intervals. Extracts were recovered by liquid–solid phase separation, and the liquid volume was reduced under a gentle stream of nitrogen. The sample cleanup was performed with a Florisil column deactivated at 1% (3 g) and eluted with 5 mL of ethyl acetate. The volume was then reduced under a gentle stream of nitrogen, and 125 ng of triphenylamine was added as an internal standard, yielding a final volume of 300 μL. The cleaned samples were injected into a Bruker 320-MS GC-MS/MS.
The surrogate recoveries for the acidic and neutral compounds and fragrances were 81 ± 4 %, 87 ± 6%, and 82 ± 8%, respectively. The correlation coefficients (r2) of the calibration curves always exceeded 0.999. Table 2 shows the detection and quantification limits.

2.3.3. Extractable Organic Matter

The extractable organic matter (EOM) contained in the gravel was determined by gravimetry. Approximately 1 mL of extract that had been previously obtained was added to a Petri dish and placed in an oven for 1 h at 105 °C, at which point a constant weight was reached.

2.4. Statistics Analyses

The experimental results were statistically evaluated using STATA® software, release 9. In this study, these analyses were performed on the data corresponding to concentrations achieved in the influent and the effluents from AS and HSSFs. Statistical significance differences of OMP concentration after each treatment (AS and HSSFs) compared to influent samples were tested by Wilcoxon signed-rank test (non-parametric test), since data do not exhibit a symmetric or normal distribution against a null hypothesis of no difference. A significance level of p = 0.05 was considered statistically significant.

3. Results and Discussion

3.1. Conventional Water Quality Parameters of Influent and Effluents from AS and HSSFs

Table 2 shows the average concentrations of water quality parameters of influent and effluents from AS and HSSFs. Regarding the in situ parameters such pH and temperature, the values varied between 7.0–8.5 and 16–17 °C in the influent and effluents evaluated without significant differences between AS and HSSF effluents. However, a significant difference between AS and HSSF effluents was reported for EC values. In this case, HSSF effluent had EC 1.7 times higher than the AS effluent. Evapotranspiration process that takes place in the HSSF system was responsible for the salinity increment of the effluent [29].
According to the classification established by Henze et al. [30], the influent used in this study can be classified such as “diluted” wastewater due to the concentration of COD, BOD5, and TOC of 274, 184, and 83 mg/L, respectively. These values are similar to those reported by Leiva et al. [31] and Burgos et al. [32]. However, the NH4+-N concentration of the influent corresponds to a “concentrated” wastewater with values above 80 mg/L [30]. These behaviors are possibly related to the water use and the economic activity of the rural community focused on the agriculture. Figure 3 summarizes the mean removal efficiencies of water quality parameters for AS and HSSFs. In general, the AS system achieved higher performance of pollutants with average values between 74%–99% than the HSSF system which reported values between 35%–80%. For organic matter removals that included parameters such TSS, VSS, COD, BOD5, and TOC, AS reported average percentages above 85%. In the case of HSSFs, the higher performance was 77% which was achieved by the removal of TSS and VSS. The same tendency was observed in Matamoros et al. [20] where the removal of COD on the AS system was 40% higher than on HSSF system in warm season. Moreover, they affirmed that AS had the best removal performance for all the studied water quality parameters compared to other technologies such CWs, RBC, and SP due to the forced aeration process that takes place in AS. This characteristic also influenced the removal of NH4+-N in AS which had a mean performance of 74.6%. As shown Table 2, the DO and ORP concentrations of AS proved the aerobic conditions of this system with values that ranged between 300–457 mV and 4.25–7.32 mg/L, respectively. With these conditions (DO > 1.5 mg/L), nitrification takes place in the AS system which is considered the main pathway for NH4+-N [33,34]. On the contrary, it is known that HSSFs promote anaerobic conditions [30]. In this system, the DO and ORP values fluctuated between 0.07–0.84 mg/L and (−241)–(−341) mV, respectively.

3.2. Occurrence of OMPs in the Influent

The OMPs included in this study were selected based on the concentrations and frequencies of detection reported by several authors for surface water and WWTP effluents [5,35]. Table 3 shows mean, median, and range of concentrations (n = 4–5) for all the OMP compounds studied in the influent and effluents of the evaluated systems. The OMPs detected in the influent were naproxen, ibuprofen, diclofenac, carbamazepine, caffeine, triclosan, methyl dihydrojasmonate, galaxolide, and bisphenol-A. The concentrations of micropollutants in the influent ranged from 0.16 to 7.75 μg/L (Table 2).
Ibuprofen, caffeine, and methyl dihydrojasmonate were the most abundant compounds in influent with concentrations of 7.7, 7.3, and 3.5 μg/L, respectively. These values are in the ranges found by Luo et al. [5] who evaluated the occurrence of OMPs in the influent of WWTPs. In this study, the concentration of ibuprofen and caffeine varied between 0.004–603 μg/L and 0.22–209 μg/L, respectively. However, the concentration of methyl dihydrojasmonate found in this study was approximately 50% lower than those reported by Matamoros et al. [18] and Hijosa-Valsero et al. [16] in influent of CWs. These values varied between 7.0–8.0 μg/L. These results are expected due to their physicochemical properties. These compounds (ibuprofen, caffeine, and methyl dihydrojasmonate) have hydrophilic characteristics with the octanol-water partition coefficient (LogKow) of 3.79, 0.16, and 2.98, respectively as shown Table 1.
Carbamazepine, triclosan, and bisphenol-A were found in low concentrations with values of 0.22, 0.20, and 0.16 μg/L, respectively. Comparing with literature, carbamazepine and triclosan are similar to those concentration reported in the literature. These values found in wastewater effluent varied between 1–1194 ng/L and 0.03–23.90 μg/L, respectively [5,36]. Moreover, the low concentration of bisphenol-A is associated with its characteristics of moderate solubility (water solubility: 146.15 mg/L) (Table 1) and because it can be partially adsorbed by sediments (Koc: 1245 L/kg).
Regarding transformation products, the compounds detected were carboxy-ibuprofen, 1-hydroxy-ibuprofen, 2-hydroxy-ibuprofen, and ibuprofen amide with concentrations of 54 μg/L, 8.32 μg/L, 29 μg/L, and 0.56 μg/L, respectively. The high concentrations of transformation products from ibuprofen are due to its widespread use in pharmaceuticals. Studies reported that carboxy-ibuprofen, 1-hydroxy ibuprofen, and 2-hydroxy ibuprofen are the main ibuprofen metabolites generated in biotransformation and biodegradation in the human body [30,37]. It is estimated that 15% of ibuprofen that is consumed is excreted as the parent compound, 26% is excreted as hydroxy ibuprofen, and 43% as carboxy-ibuprofen [38]. However, recent studies have reported that these OMPs are also generated in the biodegradation that occurs in WWTPs [39]. In this study, carboxy-ibuprofen and 2-hydroxy-ibuprofen were found to have higher concentrations in the influent than those reported by Hijosa-Valsero et al. [16]. In this case, the concentrations of these compounds were 7.84 and 12.1 μg/L, respectively.
On the other hand, Table 4 shows the average concentrations for the OMPs detected in the particulate phase. Carbamazepine, triclosan, tonalide, galaxolide, and bisphenol-A were detected. Galaxolide was the most abundant compound with a concentration of 0.55 μg/L, whereas carbamazepine, triclosan, and bisphenol-A achieved low concentrations ranging from 0.02 to 0.14 μg/L. This result was expected because galaxolide had a log Kow above 6.0 which indicated that this compound is hydrophobic and tends to be adsorbed by the solid phase [40].

3.3. Ocurrence of OMPs in Biosolids

Table 5 shows the EOM and OMPs in the AS biosolids and the HSSF gravel bed biomass. For the AS biosolids, the EOM values achieved were 1912 μg/kg∙dry weight (DW). In the case of HSSF system, the EOM values were 246, 225, and 101 μg/kg∙DW for Zones A, B, and C, respectively. These results were lower than those reported by Hijosa-Valsero et al. [16] which presented values between 50–160 mg/kg∙DW. Regarding the OMPs, the highest concentrations in the AS biosolids were galaxolide and 1-hydroxy ibuprofen with concentrations of 0.37 μg/kg∙DW and 0.11 μg/kg∙DW, respectively. The same tendency was observed in HSSF gravel bed biomass where galaxolide and 1-hydroxy ibuprofen had 0.001–0.020 μg/kg∙DW and 0.006–0.009 μg/kg∙DW, respectively, for Zones A, B, and C. For galaxolide and 2-hydroxy ibuprofen, the concentrations decreased by 95% and 50%, respectively along the HSSFs bed (from Zone A to Zone C). These difference along the longitudinal profile of HSSFs revealed that the highest removal of these compounds takes place within the first meter of the inflow zone (Zone A). This tendency was observed by Carranza-Diaz et al. [41] who evaluated the evolution of concentrations of three selected OMPs along the CWs. The concentration of caffeine decreased in 75% within the first 1.2 m of the inflow zone. Moreover, Vymazal and Kröpfelová [42] reported that removal of contaminants takes place within the first meters of CW beds.

3.4. Removal Efficiencies of OMPs

Figure 4 shows the removal efficiencies of the OMPs in the AS and HSSF system. The removal efficiencies of OMPs and their transformation products was determined by their physicochemical properties and the operating parameters of the treatment systems.
Regarding naproxen and ibuprofen removals by both systems (AS and HSSFs), significant differences were observed (p < 0.05). In the case of the AS system, these compounds were efficiently removed with performances above 95%. However, they were partially removed by the HSSF system with values that varied between 55%–68%. Matamoros et al. [20] observed the same tendency with differences of 50% and 88% between AS and HSSFs for naproxen and ibuprofen, respectively. This behavior was expected because naproxen and ibuprofen are eliminated mainly under aerobic conditions or positive ORP [43]. In this study, the ORP values varied between 300–457 mV in AS systems. Under anaerobic conditions which promote HSSF system (ORP: (−241)–(−341) mV and DO: 0.07–0.84 mg/L), the removal of naproxen and ibuprofen is variable. Alvarino et al. [44] evaluated the removal efficiencies of naproxen and ibuprofen in an anaerobic reactor. As reported in this study, naproxen can be removed under both aerobic and anaerobic conditions, whereas ibuprofen is recalcitrant to biodegradation under anaerobic conditions achieving performance below 15%. Moreover, it was reported that the removal of ibuprofen and naproxen in HSSF system varies seasonally. In this context, Hijosa-Valsero et al. [45] reported removal efficiencies below 45% for both compounds in winter, whereas in summer, over 90% was removed.
In the case of diclofenac, this compound was effectively removed by both systems (AS and HSSFs) with average percentages above 70% (p > 0.05). An opposite result was observed by Matamoros et al. [20] which showed a difference of 22% between AS and HSSFs in warm season. However, it is important to mention that these removal efficiencies achieved in this study were highly variable and ranged between 0%–90%. These results are in agreement with Ávila et al. [46] and Clara et al. [47]. Negative removal efficiencies (below 0%) may appear due to the conversion of their glucuronides and other transformations products to their parent compound through enzymatic processes in the WWTPs [48].
Regarding carbamazepine removal, the efficiencies achieved were 25% and 23% for AS and HSSFs, respectively without significant difference (p > 0.05). It is well known that carbamazepine is a recalcitrant compound that is not easily removed by conventional AS [44,47] or HSSF systems [22,45]. The recalcitrance of carbamazepine is due to heterocyclic structures such as pyridine. Moreover, uracils and furans are resistant to biodegradation under anaerobic conditions (ORPs below −70 mV) [49]. Park et al. [50] indicated that different CW configuration systems rarely remove more than 60% of carbamazepine. However, Dordio et al. [4] observed higher removal efficiencies (88% in winter and 97% in summer) for a microcosm-scale CW planted with Typha spp., where clay was used as a substrate, suggesting that carbamazepine can be removed mainly through sorption.
As expected, the removal of caffeine was above 90% in both systems without significant difference between AS and HSSFs. Other studies have indicated that this pharmaceutical is easily removed by WWTPs (higher than 90%) [5,47] and CWs [18,22]. Moreover, caffeine biodegradation is due to the hydrophilic properties (log Kow: 0.16) (Table 1) and is easily degraded by enzymatic complexes of microorganisms by demethylation [51]. The same tendency was observed for methyl dihydrojasmonate in which removal efficiencies were above 85% without a significant difference between AS and HSSFs. The structural simplicity of this molecule indicates that it can be removed by biodegradation (Table 1). By contrast, the lipophilic fragrance galaxolide (log Kow: 5.90) is removed mainly by sorption, which can occur in WWTPs or CWs [22,45]. In fact, in this study, galaxolide was determined in the particulate and dissolved fractions, AS and HSSF biosolids (Table 5). The removal efficiency of galaxolide from the dissolved fraction was 15% for AS and 50 % for HSSFs.
On the other hand, the removal efficiency of bisphenol-A in AS reached 87%. This is in agreement with Staples et al. [52], who found that bisphenol-A is easily biodegraded by WWTPs (half-live of 2.5 to 4 days). Several authors reported that up to 90% of bisphenol-A is removed by conventional WWTPs [47,53]. In contrast, the HSSF system was able to remove only 55% of bisphenol-A due to the system’s low ORP (below −241 mV). Moreover, Ávila et al. [46] showed 65% removal of bisphenol-A under anaerobic conditions. They also showed that the biodegradation of bisphenol-A can be improved under oxidizing conditions in CWs. In addition, Navia et al. [54] found that compounds with phenols structure can be removed by sorption.
In the case of triclosan, the removal of this compound was 30% higher in the AS than in the HSSFs (p < 0.05). Similar results were observed in Matamoros et al. [22] where the removal of these compounds in AS system achieved 59% higher than in HSSF system. Several authors suggested that the triclosan removal mechanism by WWTPs is adsorption under aerobic conditions at efficiencies that ranged from 66% to 82% [36,55,56].
Regarding the transformation products, over 97% of carboxy-ibuprofen, 1-hydroxy ibuprofen, and 2-hydroxy ibuprofen was removed by AS. In contrast, the HSSF system had less effective removal percentages of 29%, 67%, and 25% for carboxy-ibuprofen, 1-hydroxy ibuprofen, and 2-hydroxy ibuprofen, respectively. Ibuprofen and its transformation products are easily removed by AS and HSSFs, but their removal efficiencies depend on operating conditions and system design [35]. Bendz et al. [57] showed removals of 95% and exceeding 96% for hydroxy ibuprofen and carboxy ibuprofen, respectively, which may have been due to the operating conditions of the AS system. Ferrando-Climent et al. [39] found that ibuprofen, carboxy-ibuprofen, and 2-hydroxy ibuprofen were easily removed by WWTPs, but 1-hydroxy ibuprofen presented some recalcitrance to biodegradation.
The results of this study showed that the AS system achieved better performances for removing OMPs than CWs. In general, the removal efficiencies of OMPs in AS technology were above 70%, except for galaxolide and carbamazepine where this system achieved percentages below 30%. This difference between AS and HSSF systems was also observed by Qiang et al. [23]. In this case, the removal efficiencies of some OMPs in AS varied between 72%–99% whereas CWs presented performances between 50%–79%. Moreover, Matamoros et al. [22] showed the same tendency where the average removal efficiency of OMPs in AS was 1.5 times higher than CWs. Although AS technology is effective for removing these types of compounds, one disadvantage is related to temperature. Some studies revealed that during warm conditions, the removal efficiencies decreased by up to 50% [22,23,58]. Moreover, the comparison of different wastewater treatment technologies should not only consider the performances achieved by different systems. It is important to determine the population that will use this technology. For rural areas, AS is not a good alternative because this technology has a high cost of construction and its operation needs trained professionals. CWs are a feasible option due to their better landscape integration and their low maintenance costs [59]. In this study, HSSF reported the lowest overall removal efficiency with average removal efficiency of 55%. As these systems promote anaerobic conditions, some OMPs were not removed efficiently [60]. Unsaturated systems such as VSSFs that are operated under aerobic conditions, reported for galaxolide, methyl dihydrojasmonate, tonalide, diclofenac, and ibuprofen removal efficiencies of 88%–99%, 78%–99%, 75%–82%, 57%–73%, and 55%–99%, respectively [61,62,63]. For future studies, it is necessary to consider other configurations such as VSSFs or hybrid systems that ensure higher performance. Also, OMPs removal will be important to consider tertiary treatment via physical processes [9,64] or advanced oxidation processes [65] can reduce the recalcitrant compounds by adsorption and destruction, respectively.

4. Conclusions

Conflicting results have been reported when comparing the performance of conventional and non-conventional technologies on the OMPs removal that are presented in wastewater. In the case of this study, the results showed that the AS system had the best removal performance of contaminants. Regarding water quality parameters, the removal efficiencies of organic matter and nutrients in AS varied between 74%–99% whereas in HSSFs, these values fluctuated between 35%–80%. The same tendency was observed in the removal of OMPs where significant differences of 35%, 48%, 33%, 30%, 77%, and 69% were determined for naproxen, ibuprofen, bisphenol A, triclosan, 2-hydroxy ibuprofen, and carboxy ibuprofen between AS and HSSFs, respectively (p < 0.05). In the case of these compounds, the removal or biodegradation was performed more efficiently in aerobic conditions. Only for galaxolide, the removal efficiencies achieved by HSSF was three times higher than in AS (p < 0.05). Moreover, in both systems (AS and HSSF), carbamazepine, due to its chemical properties, was difficult to be removed with performance between 23%–25%. Despite the lower performances on OMPs removal achieved by HSSF, several modifications on the design and operational characteristics of these systems are necessary to ensure the use of non-conventional technologies in rural areas.

Author Contributions

Conceptualization, C.R.C. and G.V.; methodology, C.R.C. and J.M.B.; software, C.D.; validation, C.R.C., A.M.L., D.L. and G.V.; formal analysis, C.R.C., A.M.L., D.L.; investigation, C.R.C.; resources, J.M.B., G.V., C.R.C.; data curation, C.D.; writing—original draft preparation, C.R.C., D.L., A.M.L.

Funding

This research was funded by CONICYT, grants: FONDECYT Postdoctoral 3140162, CONICYT-PFCHA/Doctorado Nacional/2019-21191116 and CONICYT/FONDAP/15130015.

Acknowledgments

This study was funded by the following grants: FONDECYT Postdoctoral 3140162 and CONICYT/FONDAP/15130015. A.M.L. thanks CONICYT for her Scholarship Program CONICYT-PFCHA/Doctorado Nacional/2019-21191116, for supporting her Ph.D. studies at the University of Concepción.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Chamorro, S.; Hernández, V.; Matamoros, V.; Domínguez, C.; Becerra, J.; Vidal, G.; Piña, B.; Bayona, J.M. Chemical characterization of organic microcontaminant sources and biological effects in riverine sediments impacted by urban sewage and pulp mill discharges. Chemosphere 2013, 90, 611–619. [Google Scholar] [CrossRef] [PubMed]
  2. Stuart, M.; Lapworth, D.; Crane, E.; Hart, A. Review of risk from potential emerging contaminants in UK groundwater. Sci. Total Environ. 2012, 416, 1–21. [Google Scholar] [CrossRef] [PubMed]
  3. Correa, J.; Domínguez, V.; Martínez, M.; Vidal, G. Interaction between 2,4,6-TCP increasing concentration content in ECF bleached effluent and aerobic bacteria degradative activity. Environ. Int. 2003, 29, 459–465. [Google Scholar] [CrossRef]
  4. Dordio, A.; Carvalho, A.P.; Teixeira, D.M.; Dias, C.B.; Pinto, A.P. Removal of pharmaceuticals in microcosm constructed wetlands using Typha spp. and LECA. Bioresour. Technol. 2010, 101, 886–892. [Google Scholar] [CrossRef] [PubMed]
  5. Vidal, G.; Becerra, J.; Hernández, V.; Decap, J.; Xavier, C.R. Anaerobic biodegradation of sterols contained in kraft mill effluents. J. Biosci. Bioeng. 2007, 104, 476–480. [Google Scholar] [CrossRef] [PubMed]
  6. Liu, J.L.; Wong, M.H. Pharmaceuticals and personal care products (PPCPs): A review on environmental contamination in China. Environ. Int. 2013, 59, 208–224. [Google Scholar] [CrossRef] [PubMed]
  7. Neumann, P.; González Vidal, G. Sequential ultrasound and low temperature thermal pretreatment: Process optimization and influence on sewage sludge solubilization, enzyme activity and anaerobic digestion. Bioresour. Technol. 2017, 234, 178–187. [Google Scholar] [CrossRef]
  8. Grandclément, C.; Seyssiecq, I.; Piram, A.; Wong-Wah-Chung, P.; Vanot, G.; Tiliacos, N.; Roch, N.; Doumenq, P. From the conventional biological wastewater treatment to hybrid processes, the evaluation of organic micropollutant removal: A review. Water Res. 2017, 111, 297–317. [Google Scholar] [CrossRef]
  9. Vidal, G.; Navia, R.; Levet, L.; Mora, M.L.; Diez, M.C. Kraft mill anaerobic effluent color enhancement by a fixed-bed adsorption system. Biotechnol. Lett. 2001, 23, 861–865. [Google Scholar] [CrossRef]
  10. Carballa, M.; Omil, F.; Lema, J.M.; Llompart, M.; García-Jares, C.; Rodríguez, I.; Gómez, M.; Ternes, T. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res. 2004, 38, 2918–2926. [Google Scholar] [CrossRef]
  11. Kosma, C.I.; Lambropoulou, D.A.; Albanis, T.A. Investigation of PPCPs in wastewater treatment plants in Greece: Occurrence, removal and environmental risk assessment. Sci. Total Environ. 2014, 466, 421–438. [Google Scholar] [CrossRef] [PubMed]
  12. Radjenović, J.; Petrović, M.; Barceló, D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res. 2009, 43, 831–841. [Google Scholar] [CrossRef] [PubMed]
  13. Ziylan, A.; Ince, N.H. The occurrence and fate of anti-inflammatory and analgesic pharmaceuticals in sewage and fresh water: Treatability by conventional and non-conventional processes. J. Hazard. Mater. 2011, 187, 24–36. [Google Scholar] [CrossRef] [PubMed]
  14. Ávila, C.; Bayona, J.M.; Martín, I.; Salas, J.J.; García, J. Emerging organic contaminant removal in a full-scale hybrid constructed wetland system for wastewater treatment and reuse. Ecol. Eng. 2015, 80, 108–116. [Google Scholar] [CrossRef]
  15. Vera, I.; García, J.; Sáez, K.; Moragas, L.; Vidal, G. Performance evaluation of eight years experience from constructed wetlands systems in Catalonia as alternative treatment for small communities. Ecol. Eng. 2011, 37, 364–371. [Google Scholar] [CrossRef]
  16. Kadlec, R.H.; Wallace, S.D. Treatment Wetlands; CRC Press: Boca Raton, FL, USA, 2009. [Google Scholar]
  17. Hijosa-Valsero, M.; Reyes-Contreras, C.; Dominguez, C.; Bécares, E.; Bayona, J.M. Behaviour of pharmaceuticals and personal care products in constructed wetland compartments: Influent, effluent, pore water, substrate and plant roots. Chemosphere 2016, 145, 508–517. [Google Scholar] [CrossRef]
  18. Vymazal, J.; Březinová, T.D.; Koželuh, M.; Kule, L. Occurrence and removal of pharmaceuticals in four full-scale constructed wetlands in the Czech Republic—The first year of monitoring. Ecol. Eng. 2017, 98, 354–364. [Google Scholar] [CrossRef]
  19. Matamoros, V.; Arias, C.; Brix, H.; Bayona, J.M.; Arias, C.A. Preliminary screening of small-scale domestic wastewater treatment systems for removal of pharmaceutical and personal care products. Water Res. 2009, 43, 55–62. [Google Scholar] [CrossRef]
  20. Matamoros, V.; Salvadó, V. Evaluation of the seasonal performance of a water reclamation pond-constructed wetland system for removing emerging contaminants. Chemosphere 2012, 86, 111–117. [Google Scholar] [CrossRef]
  21. Matamoros, V.; Rodríguez, Y.; Albaigés, J. A comparative assessment of intensive and extensive wastewater treatment technologies for removing emerging contaminants in small communities. Water Res. 2016, 88, 777–785. [Google Scholar] [CrossRef]
  22. Verlicchi, P.; Zambello, E. How efficient are constructed wetlands in removing pharmaceuticals from untreated and treated urban wastewaters? A review. Sci. Total Environ. 2014, 470, 1281–1306. [Google Scholar] [CrossRef] [PubMed]
  23. Matamoros, V.; Bayona, J.M. Elimination of Pharmaceuticals and Personal Care Products in Subsurface Flow Constructed Wetlands. Environ. Sci. Technol. 2006, 40, 5811–5816. [Google Scholar] [CrossRef] [PubMed]
  24. Qiang, Z.; Dong, H.; Zhu, B.; Qu, J.; Nie, Y. A comparison of various rural wastewater treatment processes for the removal of endocrine-disrupting chemicals (EDCs). Chemosphere 2013, 92, 986–992. [Google Scholar] [CrossRef] [PubMed]
  25. Ahmed, M.B.; Zhou, J.L.; Ngo, H.H.; Guo, W.; Thomaidis, N.S.; Xu, J. Progress in the biological and chemical treatment technologies for emerging contaminant removal from wastewater: A critical review. J. Hazard. Mater. 2017, 323, 274–298. [Google Scholar] [CrossRef] [PubMed]
  26. Melvin, S.D.; Leusch, F.D. Removal of trace organic contaminants from domestic wastewater: A meta-analysis comparison of sewage treatment technologies. Environ. Int. 2016, 92, 183–188. [Google Scholar] [CrossRef] [PubMed]
  27. Sepúlveda-Mardones, M.; Lopez, D.; Vidal, G. Methanogenic activity in the biomass from horizontal subsurface flow constructed wetlands treating domestic wastewater. Ecol. Eng. 2017, 105, 66–77. [Google Scholar] [CrossRef]
  28. López, D.; Fuenzalida, D.; Vera, I.; Rojas, K.; Vidal, G. Relationship between the removal of organic matter and the production of methane in subsurface flow constructed wetlands designed for wastewater treatment. Ecol. Eng. 2015, 83, 296–304. [Google Scholar] [CrossRef]
  29. American Public Health Association (APHA). Standard Methods for the Examination of Wastewater; APHA Publishing: Washington, DC, USA, 2005. [Google Scholar]
  30. Masi, F.; Martinuzzi, N. Constructed wetlands for the Mediterranean countries: Hybrid systems for water reuse and sustainable sanitation. Desalination 2007, 215, 44–55. [Google Scholar] [CrossRef]
  31. Henze, M.; Harremoës, P.; La Cour Jansen, J.; Arvin, E. Wastewater Treatment: Biological and Chemical Processes; Springer: Heidelberg, Germany, 2002. [Google Scholar]
  32. Leiva, A.M.; Núñez, R.; Gómez, G.; Lopez, D.; Vidal, G. Performance of ornamental plants in monoculture and polyculture horizontal subsurface flow constructed wetlands for treating wastewater. Ecol. Eng. 2018, 120, 116–125. [Google Scholar] [CrossRef]
  33. Burgos, V.; Araya, F.; Reyes-Contreras, C.; Vera, I.; Vidal, G. Performance of ornamental plants in mesocosm subsurface constructed wetlands under different organic sewage loading. Ecol. Eng. 2017, 99, 246–255. [Google Scholar] [CrossRef]
  34. Ye, F.; Li, Y. Enhancement of nitrogen removal in towery hybrid constructed wetland to treat domestic wastewater for small rural communities. Ecol. Eng. 2009, 35, 1043–1050. [Google Scholar] [CrossRef]
  35. Vymazal, J.; Kröpfelová, L. Multistage hybrid constructed wetland for enhanced removal of nitrogen. Ecol. Eng. 2015, 84, 202–208. [Google Scholar] [CrossRef]
  36. Verlicchi, P.; Al Aukidy, M.; Zambello, E. Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after a secondary treatment—A review. Sci. Total Environ. 2012, 429, 123–155. [Google Scholar] [CrossRef]
  37. Lozano, N.; Rice, C.P.; Ramirez, M.; Torrents, A. Fate of Triclocarban, Triclosan and Methyltriclosan during wastewater and biosolids treatment processes. Water Res. 2013, 47, 4519–4527. [Google Scholar] [CrossRef] [PubMed]
  38. Ternes, T.A.; Joss, A.; Siegrist, H. Peer Reviewed: Scrutinizing Pharmaceuticals and Personal Care Products in Wastewater Treatment. Environ. Sci. Technol. 2004, 38, 392A–399A. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Buser, H.-R.; Poiger, T.; Müller, M.D. Occurrence and Environmental Behavior of the Chiral Pharmaceutical Drug Ibuprofen in Surface Waters and in Wastewater. Environ. Sci. Technol. 1999, 33, 2529–2535. [Google Scholar] [CrossRef]
  40. Ferrando-Climent, L.; Collado, N.; Buttiglieri, G.; Gros, M.; Rodríguez-Roda, I.; Rodríguez-Mozaz, S.; Barceló, D. Comprehensive study of ibuprofen and its metabolites in activated sludge batch experiments and aquatic environment. Sci. Total Environ. 2012, 438, 404–413. [Google Scholar] [CrossRef]
  41. Clara, M.; Gans, O.; Windhofer, G.; Krenn, U.; Hartl, W.; Braun, K.; Scharf, S.; Scheffknecht, C. Occurrence of polycyclic musks in wastewater and receiving water bodies and fate during wastewater treatment. Chemosphere 2011, 82, 1116–1123. [Google Scholar] [CrossRef]
  42. Carranza-Diaz, O.; Schultze-Nobre, L.; Moeder, M.; Nivala, J.; Kuschk, P.; Koeser, H. Removal of selected organic micropollutants in planted and unplanted pilot-scale horizontal flow constructed wetlands under conditions of high organic load. Ecol. Eng. 2014, 71, 234–245. [Google Scholar] [CrossRef]
  43. Vymazal, J.; Kröpfelová, L. Removal of organics in constructed wetlands with horizontal sub-surface flow: A review of the field experience. Sci. Total Environ. 2009, 407, 3911–3922. [Google Scholar] [CrossRef]
  44. Zwiener, C.; Frimmel, F. Short-term tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric acid, ibuprofen, and diclofenac. Sci. Total Environ. 2003, 309, 201–211. [Google Scholar] [CrossRef]
  45. Alvarino, T.; Suarez, S.; Lema, J.; Omil, F. Understanding the removal mechanisms of PPCPs and the influence of main technological parameters in anaerobic UASB and aerobic CAS reactors. J. Hazard. Mater. 2014, 278, 506–513. [Google Scholar] [CrossRef] [PubMed]
  46. Hijosa-Valsero, M.; Matamoros, V.; Pedescoll, A.; Martín-Villacorta, J.; Bécares, E.; García, J.; Bayona, J.M. Evaluation of primary treatment and loading regimes in the removal of pharmaceuticals and personal care products from urban wastewaters by subsurface-flow constructed wetlands. Int. J. Environ. Anal. Chem. 2011, 91, 632–653. [Google Scholar] [CrossRef]
  47. Avila, C.; Pedescoll, A.; Matamoros, V.; Bayona, J.M.; García, J. Capacity of a horizontal subsurface flow constructed wetland system for the removal of emerging pollutants: An injection experiment. Chemosphere 2010, 81, 1137–1142. [Google Scholar] [CrossRef] [PubMed]
  48. Clara, M.; Strenn, B.; Gans, O.; Martinez, E.; Kreuzinger, N.; Kroiss, H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res. 2005, 39, 4797–4807. [Google Scholar] [CrossRef]
  49. Kimura, K.; Hara, H.; Watanabe, Y. Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs). Desalination 2005, 178, 135–140. [Google Scholar] [CrossRef]
  50. Adrian, N.R.; Suflita, J.M. Anaerobic biodegradation of halogenated and nonhalogenated N-, s-, and o-heterocyclic compounds in aquifer slurries. Environ. Toxicol. Chem. 1994, 13, 1551–1557. [Google Scholar] [CrossRef]
  51. Park, N.; Vanderford, B.J.; Snyder, S.A.; Sarp, S.; Kim, S.D.; Cho, J. Effective controls of micropollutants included in wastewater effluent using constructed wetlands under anoxic condition. Ecol. Eng. 2009, 35, 418–423. [Google Scholar] [CrossRef]
  52. Buerge, I.J.; Poiger, T.; Müller, M.D.; Buser, H.-R. Caffeine, an Anthropogenic Marker for Wastewater Contamination of Surface Waters. Environ. Sci. Technol. 2003, 37, 691–700. [Google Scholar] [CrossRef]
  53. Staples, C.A.; Dome, P.B.; Klečka, G.M.; Oblock, S.T.; Harris, L.R. A review of the environmental fate, effects, and exposures of bisphenol A. Chemosphere 1998, 36, 2149–2173. [Google Scholar] [CrossRef]
  54. Froehner, S.; Piccioni, W.; Machado, K.S.; Aisse, M.M. Removal Capacity of Caffeine, Hormones, and Bisphenol by Aerobic and Anaerobic Sewage Treatment. Water Air Soil Pollut. 2011, 216, 463–471. [Google Scholar] [CrossRef]
  55. Navia, R.; Levet, L.; Mora, M.L.; Vidal, G.; Díez, M.C. Allophanic Soil Adsorption System as a Bleached Kraft Mill Aerobic Effluent Post-Treatment. Water, Air, Soil Pollut. 2003, 148, 323–333. [Google Scholar] [CrossRef]
  56. Federle, T.W.; Kaiser, S.K.; Nuck, B.A. Fate and effects of triclosan in activated sludge. Environ. Toxicol. Chem. 2002, 21, 1330–1337. [Google Scholar] [CrossRef] [PubMed]
  57. Ying, G.-G.; Yu, X.-Y.; Kookana, R.S. Biological degradation of triclocarban and triclosan in a soil under aerobic and anaerobic conditions and comparison with environmental fate modelling. Environ. Pollut. 2007, 150, 300–305. [Google Scholar] [CrossRef] [PubMed]
  58. Bendz, D.; Paxéus, N.A.; Ginn, T.R.; Loge, F.J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J. Hazard. Mater. 2005, 122, 195–204. [Google Scholar] [CrossRef] [PubMed]
  59. Hijosa-Valsero, M.; Matamoros, V.; Sidrach-Cardona, R.; Martín-Villacorta, J.; Bécares, E.; Bayona, J.M. Comprehensive assessment of the design configuration of constructed wetlands for the removal of pharmaceuticals and personal care products from urban wastewaters. Water Res. 2010, 44, 3669–3678. [Google Scholar] [CrossRef] [PubMed]
  60. Polprasert, C.; Kittipongvises, S. Treatise on Water Science; Elsevier: Oxford, UK, 2011. [Google Scholar]
  61. Samaras, V.G.; Stasinakis, A.S.; Mamais, D.; Thomaidis, N.S.; Lekkas, T.D. Fate of selected pharmaceuticals and synthetic endocrine disrupting compounds during wastewater treatment and sludge anaerobic digestion. J. Hazard. Mater. 2013, 244, 259–267. [Google Scholar] [CrossRef]
  62. Matamoros, V.; Arias, C.; Brix, H.; Bayona, J.M. Removal of pharmaceuticalsand personal care products (PPCPs) from urban wastewater in a pilotvertical flow constructed wetland and a sand filter. Environ. Sci. Technol. 2007, 41, 8171–8177. [Google Scholar] [CrossRef]
  63. Reyes-Contreras, C.; Hijosa-Valsero, M.; Sidrach-Cardona, R.; Bayona, J.M.; Bécares, E. Temporal evolution in PPCP removal from urban wastewater by constructed wetlands of different configuration: A medium-term study. Chemosphere 2012, 88, 161–167. [Google Scholar] [CrossRef]
  64. Matamoros, M.; Hijosa-Valsero Bayona, J.M. Assessment of the pharmaceuticalactive compounds removal in wastewater treatment systems at enantiomeric level. Ibuprofen and naproxen. Chemosphere 2009, 75, 200–205. [Google Scholar] [CrossRef]
  65. Yeber, M.C.; Soto, C.; Riveros, R.; Navarrete, J.; Vidal, G. Optimization by factorial design of copper (II) and toxicity removal using a photocatalytic process with TiO2 as semiconductor. Chem. Eng. J. 2009, 152, 14–19. [Google Scholar] [CrossRef]
Water 11 02515 g001 550
Figure 1. Schematic diagram of activated sludge (AS) and horizontal subsurface flow (HSSF) systems.
Figure 1. Schematic diagram of activated sludge (AS) and horizontal subsurface flow (HSSF) systems.
Water 11 02515 g001
Water 11 02515 g002 550
Figure 2. Sampling points of biomass on the gravel bed of HSSF system.
Figure 2. Sampling points of biomass on the gravel bed of HSSF system.
Water 11 02515 g002
Water 11 02515 g003 550
Figure 3. Removal efficiencies (bar chart) of quality water parameters for AS ( Water 11 02515 i015) and HSSFs ( Water 11 02515 i016). Error bars represent standard deviations.
Figure 3. Removal efficiencies (bar chart) of quality water parameters for AS ( Water 11 02515 i015) and HSSFs ( Water 11 02515 i016). Error bars represent standard deviations.
Water 11 02515 g003
Water 11 02515 g004 550
Figure 4. Removal efficiencies (bar chart) of OMPs for AS ( Water 11 02515 i015) and HSSFs ( Water 11 02515 i016). (Abbreviations used: ibuprofen (IBU); naproxen (NAP); diclofenac (DIC); methyl dihydrojasmonate (MDHJ); galaxolide (GAL); caffeine (CAF); carbamazepine (CAR); bisphenol-A (BIS-A); triclosan (TRI); 2-hydroxy ibuprofen (2OH-IBU); 1-hydroxy ibuprofen (1OH-IBU) and carboxy-ibuprofen (CAR-IBU)). Error bars represent standard deviations.
Figure 4. Removal efficiencies (bar chart) of OMPs for AS ( Water 11 02515 i015) and HSSFs ( Water 11 02515 i016). (Abbreviations used: ibuprofen (IBU); naproxen (NAP); diclofenac (DIC); methyl dihydrojasmonate (MDHJ); galaxolide (GAL); caffeine (CAF); carbamazepine (CAR); bisphenol-A (BIS-A); triclosan (TRI); 2-hydroxy ibuprofen (2OH-IBU); 1-hydroxy ibuprofen (1OH-IBU) and carboxy-ibuprofen (CAR-IBU)). Error bars represent standard deviations.
Water 11 02515 g004
Table
Table 1. Physicochemical properties of the target organic micropollutants (OMPs) (pKa, Log Kow, Log Koc, and solubility values). This data was obtained from EPI suite v4.00 and Log Dow were calculated at pH 8.3.
Table 1. Physicochemical properties of the target organic micropollutants (OMPs) (pKa, Log Kow, Log Koc, and solubility values). This data was obtained from EPI suite v4.00 and Log Dow were calculated at pH 8.3.
OMPsUsespKaLog KowLog KocLog DowWater Solubility
at 25 °C (mg/L)		Molecular Structure
NaproxenAnalgesic/ anti-inflammatory4.153.101.970.2544.07 Water 11 02515 i001
Ibuprofen4.913.792.351.7057.97 Water 11 02515 i002
Diclofenac4.154.022.611.1710.89 Water 11 02515 i003
CarbamazepineAnticonvulsantn.a.2.252.28n.a.30.48 Water 11 02515 i004
CaffeineStimulant−0.070.160.98−6.9111,308 Water 11 02515 i005
TriclosanAntibacterial/ antifungal7.904.663.933.669.30 Water 11 02515 i006
Methyl dihydrojasmonateFragrancesn.a.2.982.70n.a.154.88 Water 11 02515 i007
Tonaliden.a.6.354.72n.a.0.37 Water 11 02515 i008
Galaxoliden.a.6.264.10n.a.0.20 Water 11 02515 i009
Bisphenol-AManufacture of plastics and epoxy resins8.733.643.103.63146.15 Water 11 02515 i010
1-Hydroxy ibuprofenIbuprofen transformation products4.552.250.99−3.393192 Water 11 02515 i011
2-Hydroxy ibuprofen4.632.291.01−3.312974 Water 11 02515 i012
Carboxy-ibuprofen3.971.971.25−4.031453 Water 11 02515 i013
Ibuprofen amiden.a.−2.75−1.03n.a.8083 Water 11 02515 i014
Notes: n.a.: does not apply.
Table
Table 2. Minimum, maximum (in parentheses), and average concentrations of the physicochemical and water quality parameters in the influent and effluent of AS and HSSFs (n = 8).
Table 2. Minimum, maximum (in parentheses), and average concentrations of the physicochemical and water quality parameters in the influent and effluent of AS and HSSFs (n = 8).
ParametersInfluentEffluents
ASHSSFs
pH(7.95–8.81)(6.89–7.17)(7.05–7.75)
Temperature (°C)17 (15–20)17 (15–20)16 (15–20)
EC (mS/cm)3799 (2947–4534)1962 (1574–2293)3396 (2481–4293)
ORP (mV)−229 (−291–−154)369 (300–457)−281 (−241–(−341))
DO (mg/L)0.53 (0.42–0.65)5.53 (4.25–7.32)0.24 (0.07–0.84)
COD (mg/L)274 (115–465)10.9 (4.6–18.5)74.4 (31.2–126.2)
BOD5 (mg/L)184 (48–372)0.4 (0.1–0.8)77.5 (20.2–156.8)
PO4 3−- P (mg/L)10 (5–15)1.8 (0.9–2.7)16 (14–18)
NH4+- N (mg/L)86 (31–190)21.9 (7.9–48.3)53.4 (19.2–118.0)
TC (mg/L)189 (162–210)50 (39–67)114 (97–137)
TOC (mg/L)83 (56–105)10 (7.66–15)20 (15–23)
TSS (mg/L)255 (76–565)5.6 (1.7–12.4)67.0 (20.0–148.5)
VSS (mg/L)193 (33–513)3.5 (0.6–9.4)37.6 (6.4–100.0)
Notes: EC: electrical conductivity; ORP: oxidation-reduction potential; DO: dissolved oxygen; COD: chemical oxygen demand; BOD5: biological oxygen demand; PO43−P: orthophosphate; NH4+-N: ammoniacal nitrogen; TC: total carbon; TOC: total organic carbon; TSS: total suspended solids; VSS: volatile suspended solids.
Table
Table 3. Average concentrations (µg/L) and standard deviations of OMPs and their transformation products evaluated in the influent and effluents of AS and HSSFs, respectively (n = 8).
Table 3. Average concentrations (µg/L) and standard deviations of OMPs and their transformation products evaluated in the influent and effluents of AS and HSSFs, respectively (n = 8).
OMPs (µg/L)InfluentEffluents
MeanMedianRangeASHSSFs
MeanMedianRangeMeanMedianRange
Naproxen2.29 ± 0.722.431.94–3.690.010 ± 0.0010.010.005–0.011.01 ± 0.261.140.76–1.39
Ibuprofen7.75 ± 0.968.036.11–8.610.040 ± 0.0030.030.03–0.042.62 ± 0.302.752.40–3.08
Diclofenac1.03 ± 0.300.910.76–1.510.20 ± 0.040.190.16–0.260.28 ± 0.060.290.25–0.39
Carbamazepine0.22 ± 0.050.210.19–0.310.16 ± 0.030.170.12–0.180.16 ± 0.020.150.15–0.20
Caffeine7.33 ± 1.298.155.27–8.200.12 ± 0.010.120.10–0.130.57 ± 0.150.590.37–0.69
Triclosan0.20 ± 0.060.190.15–0.300.020 ± 0.0030.020.018–0.0250.11 ± 0.040.110.06–0.14
Methyl dihydrojasmonate3.49 ± 1.543.581.04–4.890.18 ± 0.010.180.16–0.190.53 ± 0.100.550.34–0.58
Tonalide<LOD<LOD<LOD<LOD<LOD<LOD<LOD<LOD<LOD
Galaxolide1.41 ± 0.311.210.75–1.581.15 ± 0.181.110.97–1.390.73 ± 0.130.760.57–0.89
Bisphenol-A0.16 ± 0.050.130.12–0.230.020 ± 0.0020.0180.016–0.020.07 ± 0.020.060.05–0.11
1-hydroxy ibuprofen8.32 ± 1.328.227.17–10.53<LOD<LOD<LOD3.26 ± 0.353.113.02–3.66
2-hydroxy ibuprofen29.24 ±9.8729.8626.38–50.450.78 ± 0.290.720.48–1.1828 ± 227.7724.83–29.55
Carboxy-ibuprofen53.58 ± 7.9455.6542.50–60.520.21 ± 0.060.200.14–0.2841.40 ± 2.3440.3538.98–44.21
Ibuprofen amide0.56 ± 0.140.430.43–0.70<LOD<LOD<LODn.d.n.dn.d
Notes: LOD: limit of detection; n.d.: not detected.
Table
Table 4. Average concentrations (µg/L) and standard deviations of selected OMPs in the suspended solids of influent samples and effluents of AS and HSSFs (n = 8).
Table 4. Average concentrations (µg/L) and standard deviations of selected OMPs in the suspended solids of influent samples and effluents of AS and HSSFs (n = 8).
OMPs (µg/L)InfluentEffluents
ASHSSFs
Carbamazepine0.14 ± 0.050.05 ± 0.010.12 ± 0.03
Triclosan± 0.010.003 ± 0.001<LOD
Tonalide<LOD<LOD<LOD
Galaxolide0.55 ± 0.140.13 ± 0.040.37 ± 0.13
Bisphenol–A0.02 ± 0.010.006 ± 0.0010.010 ± 0.003
Notes: LOD: limit of detection.
Table
Table 5. Average concentrations and standard deviations of extractable organic matter (EOM: µg/kg), OMPs and their transformation products (µg/kg) in the AS and HSSFs biosolids (n = 3).
Table 5. Average concentrations and standard deviations of extractable organic matter (EOM: µg/kg), OMPs and their transformation products (µg/kg) in the AS and HSSFs biosolids (n = 3).
ParametersASHSSFs
Zone AZone BZone C
EOM (µg/kg)1912 ± 436246 ± 16225 ± 17101 ± 5
Triclosan (µg/kg)0.010 ± 0.0020.0030 ± 0.0005<LOD<LOD
Galaxolide (µg/kg)0.37 ± 0.030.020 ± 0.0030.0070 ± 0.00020.0010 ± 0.0001
Bisphenol-A (µg/kg)0.0010 ± 0.0001<LOD<LOD<LOD
1-Hydroxy ibuprofen (µg/kg)0.110 ± 0.0060.009 ± 0.0010.006 ± 0.001<LOD
2-Hydroxy ibuprofen (µg/kg)0.030 ± 0.0040.0020 ± 0.00030.0010 ± 0.0002<LOD
Notes: LOD: limit of detection; EOM: extractable organic matter.

Share and Cite

MDPI and ACS Style

Reyes Contreras, C.; López, D.; Leiva, A.M.; Domínguez, C.; Bayona, J.M.; Vidal, G. Removal of Organic Micropollutants in Wastewater Treated by Activated Sludge and Constructed Wetlands: A Comparative Study. Water 2019, 11, 2515. https://doi.org/10.3390/w11122515

AMA Style

Reyes Contreras C, López D, Leiva AM, Domínguez C, Bayona JM, Vidal G. Removal of Organic Micropollutants in Wastewater Treated by Activated Sludge and Constructed Wetlands: A Comparative Study. Water. 2019; 11(12):2515. https://doi.org/10.3390/w11122515

Chicago/Turabian Style

Reyes Contreras, Carolina, Daniela López, Ana M. Leiva, Carmen Domínguez, Josep M. Bayona, and Gladys Vidal. 2019. "Removal of Organic Micropollutants in Wastewater Treated by Activated Sludge and Constructed Wetlands: A Comparative Study" Water 11, no. 12: 2515. https://doi.org/10.3390/w11122515

APA Style

Reyes Contreras, C., López, D., Leiva, A. M., Domínguez, C., Bayona, J. M., & Vidal, G. (2019). Removal of Organic Micropollutants in Wastewater Treated by Activated Sludge and Constructed Wetlands: A Comparative Study. Water, 11(12), 2515. https://doi.org/10.3390/w11122515

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop